Premium
Risk of intraparenchymal hemorrhage with magnetic resonance imaging‐defined leukoaraiosis and brain infarcts
Author(s) -
Folsom Aaron R.,
Yatsuya Hiroshi,
Mosley Thomas H.,
Psaty Bruce M.,
Longstreth W. T.
Publication year - 2012
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.22690
Subject(s) - leukoaraiosis , magnetic resonance imaging , medicine , intraparenchymal hemorrhage , functional magnetic resonance imaging , neuroimaging , radiology , white matter , subarachnoid hemorrhage , psychiatry
Objective: To determine whether the burden of leukoaraiosis and the number of brain infarcts, defined by magnetic resonance imaging (MRI), are prospectively and independently associated with intraparenchymal hemorrhage (IPH) incidence in a pooled population‐based study. Methods: Among 4,872 participants initially free of clinical stroke in the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study, we assessed white matter grade (range, 0–9), reflecting increasing leukoaraiosis, and brain infarcts using MRI. Over a median of 13 years of follow‐up, 71 incident, spontaneous IPH events occurred. Results: After adjustment for other IPH risk factors, the hazard ratios (95% confidence intervals) across white matter grades 0 to 1, 2, 3, and 4 to 9 were 1.00, 1.68 (0.86–3.30), 3.52 (1.80–6.89), and 3.96 (1.90–8.27), respectively ( p for trend <0.0001). These hazard ratios were weakened only modestly ( p for trend = 0.0003) with adjustment for MRI‐defined brain infarcts. The IPH hazard ratios for 0, 1, 2, or ≥3 MRI‐defined brain infarcts were 1.00, 1.97 (1.10–3.54), 2.00 (0.83–4.78), and 3.12 (1.31–7.43) ( p for trend = 0.002), but these were substantially attenuated when adjusted for white matter grade ( p for trend = 0.049). Interpretation: Greater MRI‐defined burden of leukoaraiosis is a risk factor for spontaneous IPH. Spontaneous IPH should be added to the growing list of potential poor outcomes in people with leukoaraiosis. ANN NEUROL 2012;